FIA
IMRX icon

FNY Investment Advisers’s Immuneering IMRX Stock Holding History

FNY Investment Advisers’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99K Hold
20,000
– – 0.04% 327
2026
Q1 		$105K Buy
+20,000
New +$103K 0.05% 275

Other funds holding IMRX

S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
FCC
Flower City Capital Pittsford, New York $227M AUM 23.31% 1-Year Est. Return
BM
Berman McAleer Timonium, Maryland $864M AUM 22.02% 1-Year Est. Return
NFG
Nations Financial Group Cedar Rapids, Iowa $2.09B AUM 34.27% 1-Year Est. Return
FFWM
Future Financial Wealth Management Cincinnati, Ohio $160M AUM 21.24% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
WDA
Wendell David Associates Portsmouth, New Hampshire $947M AUM 10.27% 1-Year Est. Return

FNY Investment Advisers's IMRX Position: Q2 2026 in Review

FNY Investment Advisers held its Immuneering (IMRX) position steady in Q2 2026 at 20,000 shares worth $99K. The position accounts for 0.04% of the portfolio, ranked #327.

FNY Investment Advisers first reported a position in IMRX in Q1 2026 and has held it in 2 quarters since. The position peaked at $105K in Q1 2026. 19 funds tracked by Wall St. Rank hold IMRX as of Q2 2026.

  • FNY Investment Advisers held 20,000 shares of Immuneering worth $99K as of Q2 2026.
  • FNY Investment Advisers left its Immuneering share count unchanged in Q2 2026.
  • Immuneering made up 0.04% of FNY Investment Advisers's portfolio in Q2 2026, its #327 holding.
  • FNY Investment Advisers first reported a position in Immuneering in Q1 2026 and has held it in 2 quarters since.
  • FNY Investment Advisers's Immuneering position peaked at $105K in Q1 2026.
  • 19 funds tracked by Wall St. Rank held Immuneering as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.